Neridronato nel trattamento dell’osteogenesi imperfetta: prestazioni cliniche ed economiche di un farmaco orfano

Bisphosphonates (BPs) are osteoclast-mediated bone resorption inhibitors and the nature of the groups attached to the central carbon atom determines the drug potency. Neridronate is an injectable aminobisphosphonate, structurally similar to alendronate and pamidronate, authorized for the treatment o...

Full description

Bibliographic Details
Main Authors: Orietta Zaniolo, Mario Eandi
Format: Article
Language:English
Published: SEEd Medical Publishers 2004-09-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/795